On November 21, 2017 Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of disease-driving genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the 29th Annual Piper Jaffray Healthcare Conference. Details are as follows (Press release, Syros Pharmaceuticals, NOV 21, 2017, View Source [SID1234522201]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

29th Annual Piper Jaffray Healthcare Conference
Date: Tuesday, November 28
Presentation Time: 2:30 p.m. ET
Location: Lotte New York Palace Hotel, 455 Madison Ave, New York, NY

A live webcast of the fireside chat will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay will be available for approximately 30 days following the fireside chat.